H-Hyp(Bzl)-OMe · HCl

H-Hyp(Bzl)-OMe · HCl is an N-unprotected N-hypotaurine-like amino acid derivative presented as a hydrochloride salt, featuring a side-chain protected as a benzyl (Bzl) ether/benzyl-protected group and a methyl ester (OMe) at the carboxyl terminus. The salt form improves handling of the amino functionality for coupling chemistry while preserving the protected side-chain for orthogonal reactivity. The molecule bears a defined stereochemical arrangement at the amino acid framework, which can be carried through peptide assembly to generate stereochemically consistent analogs. Benzyl protection and ester functionality create a controlled deprotection and activation profile, enabling downstream conversion into free carboxylic acid or side-chain-unmasked intermediates for peptide and peptidomimetic synthesis.

1. Peptide Synthesis

H-Hyp(Bzl)-OMe · HCl supports peptide building block workflows by combining a free amino group (as the HCl salt) with a methyl ester handle for protected carboxyl activation strategies. The benzyl-protected side-chain can be maintained during amide bond formation, allowing selective deprotection later to reveal functional groups needed for peptide analog construction. The ester group can be converted to coupling-ready carboxyl derivatives under standard peptide synthesis conditions, aligning with common N-to-C assembly logic. The resulting Hyp-containing residues can be incorporated into linear peptides and constrained peptide motifs where side-chain unmasking after coupling is required for subsequent functionalization.

2. Side-Chain Functionalization

H-Hyp(Bzl)-OMe · HCl is suitable for side-chain functionalization routes because the benzyl-protected functionality can be removed to generate a reactive nucleophile for further derivatization. The methyl ester provides a protected carboxyl state that can be preserved during early-stage transformations, while the amino salt facilitates selective coupling or derivatization without premature side-chain exposure. Benzyl deprotection can be used to access a functional group pattern compatible with subsequent acylation, alkylation, or conjugation chemistry, supporting the preparation of modified amino acid derivatives and peptide analogs. Downstream products can serve as intermediates for mapping functional group effects in peptide science and for constructing libraries of side-chain-modified sequences.

3. Protected Amino Acid Chemistry

H-Hyp(Bzl)-OMe · HCl functions as a chiral, protecting-group-bearing amino acid derivative for orthogonal protection planning in synthetic organic chemistry. The benzyl group provides a stable protecting strategy under many coupling conditions, while the methyl ester allows controlled conversion to acids or activated derivatives when the synthetic sequence requires it. The hydrochloride salt form stabilizes the amino functionality for handling and can improve reproducibility in peptide coupling chemistry by maintaining a defined protonation state. The compound can be employed to design stepwise synthetic routes that separate side-chain deprotection from backbone activation, supporting consistent stereochemical outcomes in amino acid derivatization and peptide building block preparation.

4. Bioconjugation Intermediates

H-Hyp(Bzl)-OMe · HCl can be applied to bioconjugation intermediate preparation where protected amino acid fragments are used to introduce defined stereochemical motifs into larger biomolecule constructs. The amino functionality enables formation of amide linkages to carrier proteins, linkers, or scaffold molecules after conversion of the ester to an appropriate reactive carboxyl form. Benzyl-protected side-chain chemistry supports orthogonal unmasking, allowing conjugation to be timed to match downstream labeling or immobilization steps. The resulting conjugatable intermediates can be used in chemical biology workflows that require controlled incorporation of amino acid-derived motifs into peptide-based probes, affinity reagents, or functional biomolecule linkers.

5. Pharmaceutical Intermediate Preparation

H-Hyp(Bzl)-OMe · HCl is relevant to pharmaceutical intermediate preparation and process chemistry due to its protected amino acid architecture that supports controlled transformation into coupling-ready or formulation-relevant derivatives. The methyl ester and benzyl-protected side-chain enable stepwise manufacturing sequences in which functional group exposure is delayed until the appropriate stage, reducing side reactions during scale-up. The hydrochloride salt form supports predictable handling of the amine in synthetic operations and can facilitate reproducible conversion to activated carboxyl intermediates for further synthesis. The compound can therefore be used as a chiral amino acid intermediate for producing peptide-like building blocks, peptidomimetic fragments, and downstream specialty chemical intermediates used in industrial chemical manufacturing.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry